ImmunotherapyLeukemiaLymphomaPersonalized MedicineTelling Patients About CAR T-Cell Therapy
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Video Library – March 6, 2019 The Children's Hospital of Philadelphia, Philadelphia, PA
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Recommended For You
LeukemiaThe chemotherapy-free combination of venetoclax plus obinutuzumab has shown efficacy and tolerability in older patients with chronic lymphocytic leukemia. Adding acalabrutinib, a new targeted agent, may enhance the clinical benefits of this regimen, according to results of a clinical trial.
LeukemiaCancer specialists are now able to use a new scoring system to decide when to start treatment for patients who have been diagnosed with chronic lymphocytic leukemia.
LeukemiaAlliance A041702 is a large clinical trial that is exploring whether adding venetoclax to the combination of ibrutinib and obinutuzumab can improve outcomes in patients with chronic lymphocytic leukemia.
LeukemiaAccording to results from a recent study, patients with chronic lymphocytic leukemia are more likely to survive for longer time periods if their posttreatment tests show no evidence of residual disease.
Last modified: March 25, 2019
